Sign In for increased benefits

Turn your one-off questions into a powerhouse research hub.

  • 🚨Real-time alerts on your custom watchlists
  • 🔍Unlock Deep Research Mode
  • 📊Exportable PDF/Word reports
  • 📚Revisit every question in your account history
  • ⭐Get personalised research and news based on your past questions
  • 🤝Team collaborate & annotate insights
  • 🌐Sync across devices—never lose your place
  • 👑Early-access to the next big AI features
  • 📚Continue enjoying 40 questions daily on your free account
About UsFAQsContact UsPrivacy PolicyCookies PolicyTerms and ConditionAcceptable Use PolicyData Processing Addendum
Latest EarningsEarnings ChatTopic ScanCompanies

Liquidia Corporation

LQDA

Healthcare
Biotechnology
US

Company Overview

Detailed information about Liquidia Corporation

Basic Information
Ticker: LQDA
Country: US
Headquarter: Morrisville, NC
Employees: 170
Financial Information
Market Cap: $1.2 Billion
Currency: USD
Sector: Healthcare
Industry: Biotechnology
Company Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Last Updated: May 2025

Here's what you can ask